RNASEK-C17orf49 |
|
RNASEK-C17orf49 readthrough
|
|
0.19 |
0.890 |
0.077 |
MIR4534 |
|
microRNA 4534
|
|
|
0.890 |
0.077 |
TBC1D3G |
Q6DHY5 Q6IPX1 Q8IZP1
|
TBC1 domain family member 3G
|
|
|
0.931 |
0.077 |
PCSEAT |
|
prostate cancer expressed EZH2 associated transcript
|
|
|
0.890 |
0.077 |
C17orf49 |
Q8IXM2
|
chromosome 17 open reading frame 49
|
|
6.9E-02 |
0.890 |
0.077 |
PATE1 |
Q8WXA2
|
prostate and testis expressed 1
|
|
7.4E-09 |
0.890 |
0.077 |
HMGN2P46 |
Q86SG4
|
high mobility group nucleosomal binding domain 2 pseudogene 46
|
Nucleic acid binding
|
|
0.890 |
0.077 |
H1-1 |
Q02539
|
H1.1 linker histone, cluster member
|
Nucleic acid binding
|
7.1E-08 |
0.861 |
0.077 |
HSPA7 |
P48741
|
heat shock protein family A (Hsp70) member 7
|
|
|
0.931 |
0.077 |
SAP30L-AS1 |
|
SAP30L antisense RNA 1 (head to head)
|
|
|
0.890 |
0.077 |
SHISA2 |
Q6UWI4
|
shisa family member 2
|
|
7.3E-02 |
0.931 |
0.077 |
TBC1D3C |
Q6DHY5 Q6IPX1 Q8IZP1
|
TBC1 domain family member 3C
|
|
2.5E-04 |
0.931 |
0.077 |
MYCLP1 |
P12525
|
MYCL pseudogene 1
|
Transcription factor
|
|
0.890 |
0.077 |
PSKH1 |
P11801
|
protein serine kinase H1
|
Kinase
|
0.26 |
0.931 |
0.077 |
ZNF783 |
Q6ZMS7
|
zinc finger family member 783
|
|
2.2E-06 |
0.931 |
0.077 |
RBMS3-AS3 |
|
RBMS3 antisense RNA 3
|
|
|
0.890 |
0.077 |
PSLNR |
|
prostate enriched lncRNA
|
|
|
0.931 |
0.077 |
LNC-LBCS |
|
lncRNA bladder and prostate cancer suppressor, hnRNPK interacting
|
|
|
0.890 |
0.077 |
IGSF5 |
Q9NSI5
|
immunoglobulin superfamily member 5
|
|
3.6E-17 |
1.000 |
0.077 |
CDY1B |
Q9Y6F8
|
chromodomain Y-linked 1B
|
|
|
0.931 |
0.077 |
GBX1 |
Q14549
|
gastrulation brain homeobox 1
|
Transcription factor
|
0.41 |
0.890 |
0.077 |
GLIDR |
|
glioblastoma down-regulated RNA
|
|
|
0.931 |
0.077 |
THA1P |
|
threonine aldolase 1, pseudogene
|
|
|
0.931 |
0.077 |
TBC1D3B |
A6NDS4
|
TBC1 domain family member 3B
|
|
0.22 |
0.931 |
0.077 |
EIF3L |
Q9Y262
|
eukaryotic translation initiation factor 3 subunit L
|
Nucleic acid binding
|
0.84 |
0.890 |
0.077 |